Compare IDEXX Laboratories, Inc. (IDXX) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Riot Platforms Inc — how do they compare? IDEXX Laboratories, Inc. trades at $554.6 (market cap $44.48B), while Riot Platforms Inc trades at $21.28 (market cap $7.53B). The key difference: IDEXX Laboratories, Inc. is far larger — about 5.9× Riot Platforms Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | RIOT | |
|---|---|---|
Market Cap | $44.48B | $7.53B |
Sector | Health | Technology |
52-Week High | $766.68 | $28.67 |
52-Week Low | $520.87 | $11.03 |
Enterprise Value | $45.38B | $8.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
RIOT trades at $19.90, up 8.98% today but facing bearish technical signals with the stock trading below key resistance levels. The company reported a net loss of $663.18 million in 2025 with negative profit margins, though revenue reached $647.44 million. Analyst consensus remains overwhelmingly bullish with 94% buy ratings and a $27.86 price target, representing 40% upside potential from current levels.
While Wall Street maintains strong buy recommendations, RIOT faces significant fundamental challenges with persistent losses and negative cash flow from operations. The stock's investment case hinges on successful execution of the company's strategic pivot toward high-performance computing and data center expansion, though operational losses and competitive pressures present substantial risks to shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
